 INDUCTION THERAPY: Patients receive mitoxantrone hydrochloride IV on days 1-5, etoposide IV on days 1-5, and cytarabine IV on days 1-5. Patients achieving complete response CR or CR with incomplete platelet count recovery CRp may receive up to 2 courses of induction therapy and up to 2 courses of consolidation therapy. 